| Literature DB >> 25591858 |
Tina M Rees1, Amanda H Lennartz2, Debra A Ignaut2.
Abstract
Glide force, average glide force, and glide force variability of the insulin lispro 200 units/mL pen (Eli Lilly and Company, Indianapolis, IN, USA) were compared to the Humalog KwikPen 100 units/mL pen (hereafter, KwikPen; Eli Lilly and Company, Indianapolis, IN, USA). Data were collected on 2 doses, 2 injection speeds, and 2 needle types. Insulin lispro 200 units/mL pen showed significantly lower maximum glide force, average glide force, and glide force variability than the KwikPen across all combinations of dose size, dose speed, and needle type. The lower glide force observed with the insulin lispro 200 units/mL pen offers another treatment option for patients with type 1 or type 2 diabetes who require greater than 20 units of mealtime insulin daily.Entities:
Keywords: Humalog® KwikPen® 100 units/mL; average glide force; glide force; glide force variability; insulin lispro 200 units/mL; insulin pen
Mesh:
Substances:
Year: 2015 PMID: 25591858 PMCID: PMC4604579 DOI: 10.1177/1932296814567533
Source DB: PubMed Journal: J Diabetes Sci Technol ISSN: 1932-2968